Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...

Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs. Drugmakers aren't happy.

Executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Kennedy Jr., to broker new price tags for drugs over the ... that any threats to their profits could impact the research they do to develop new drugs. Trump’s plan to accept free Air Force ...

Shares in US drugmakers were weaker, with Eli Lilly & Co, Pfizer, Bristol-Myers Squibb and Merck & Co all ... push to lower drug prices may have an “enormous” impact on the sector’s revenues ...

Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs. “Importing foreign prices from ... Monday morning. Merck, a company that ...